Barely Significant
← all excerpts

Effects of low-dose tacrolimus therapy in combination with methotrexate in patients with methotrexate-refractory rheumatoid arthritis.

Open Access Rheumatol · 2010 · PMC5074776 · PMID 27789995

Europe PMCDOI
1
hedged sentence
0.0050
closest p · 0.1× alpha
0.0050
boldest claim

The sentences

highly significantP < 0.005actually significant
The RA patients with an insufficient response to MTX who received the tacrolimus-MTX combination showed highly significant improvement in the DAS28 after 4 weeks (n = 10, baseline: 4.51 ± 0.31 to 4.03 ± 0.28, P < 0.005), 12 weeks (n = 9, baseline: 4.59 ± 0.34 to 3.38 ± 0.29, P < 0.01) and 24 weeks (n = 8, baseline: 4.45 ± 0.35 to 3.12 ± 0.34, P < 0.01) ( Figure 1 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.